This is an old revision of this page, as edited by Boghog (talk | contribs ) at 05:43, 15 June 2020 (consistent citation formatting). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision .
Revision as of 05:43, 15 June 2020 by Boghog (talk | contribs ) (consistent citation formatting)(diff ) ← Previous revision | Latest revision (diff ) | Newer revision → (diff )
Pharmaceutical compound
Urtoxazumab is a humanized monoclonal antibody against diarrhoea caused by Escherichia coli , serotype O121 . The drug is designed to bind to a toxin of this bacterium, so that it can be more easily broken down and eliminated from the body.
References
"International Nonproprietary Names for Pharmaceutical Substances (INN)" (PDF). World Health Organization.
López EL, Contrini MM, Glatstein E, González Ayala S, Santoro R, Allende D, et al. (January 2010). "Safety and pharmacokinetics of urtoxazumab, a humanized monoclonal antibody, against Shiga-like toxin 2 in healthy adults and in pediatric patients infected with Shiga-like toxin-producing Escherichia coli" . Antimicrobial Agents and Chemotherapy . 54 (1): 239–43. doi :10.1128/AAC.00343-09 . PMC 2798559 . PMID 19822704 .
Categories :
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
**DISCLAIMER** We are not affiliated with Wikipedia, and Cloudflare.
The information presented on this site is for general informational purposes only and does not constitute medical advice.
You should always have a personal consultation with a healthcare professional before making changes to your diet, medication, or exercise routine.
AI helps with the correspondence in our chat.
We participate in an affiliate program. If you buy something through a link, we may earn a commission 💕
↑